These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 5491480)

  • 21. [Primary prevention of ischemic heart disease using clofibrate. Cooperative epidemiological study].
    Geizerová H; Gyarfas I; Lamm G; Oliver M; Heady JA; Morris JN; Green K; Strasser T; Fejfar Z
    Cas Lek Cesk; 1979 Apr; 118(15):449-53. PubMed ID: 455361
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatable risk factors--hypercholesterolemia, smoking, and hypertension--after myocardial infarction: implications of the coronary drug project data for clinical management. Coronary Drug Project Research Group.
    Prim Care; 1980 Mar; 7(1):175-9. PubMed ID: 6992178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A cooperative trial on the primary prevention of ischaemic heart disease using clofibrate: design, methods, and progress.
    Heady JA
    Bull World Health Organ; 1973; 48(2):243-56. PubMed ID: 4578364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Risk factors, prognosis, treatment and rehabilitation in myocardial infarct].
    Kühns K; Wettich JE; Samwer KF
    Landarzt; 1967 Aug; 43(24):1133-43. PubMed ID: 5591693
    [No Abstract]   [Full Text] [Related]  

  • 25. Clofibrate and the prevention of ischaemic heart disease.
    N Z Med J; 1979 Jun; 89(637):435-6. PubMed ID: 289017
    [No Abstract]   [Full Text] [Related]  

  • 26. Clofibrate and the primary prevention of ischaemic heart disease.
    Br Med J; 1978 Dec; 2(6152):1585-6. PubMed ID: 728731
    [No Abstract]   [Full Text] [Related]  

  • 27. Prevention of coronary heart disease by diet.
    Leren P
    Postgrad Med J; 1975; 51(8):suppl 44-6. PubMed ID: 802722
    [No Abstract]   [Full Text] [Related]  

  • 28. Current status of research on the epidemiology of coronary heart disease.
    Keys A
    Jpn Circ J; 1968 Dec; 32(12):1669-83. PubMed ID: 5756638
    [No Abstract]   [Full Text] [Related]  

  • 29. Coronary heart disease and associated risk factors in Qazvin: a population-based study.
    Fakhrzadeh H; Bandarian F; Adibi H; Samavat T; Malekafzali H; Hodjatzadeh E; Larijani B
    East Mediterr Health J; 2008; 14(1):33-41. PubMed ID: 18557450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. W.H.O. cooperative trial on primary prevention of ischaemic heart disease using clofibrate to lower serum cholesterol: mortality follow-up. Report of the Committee of Principal Investigators.
    Lancet; 1980 Aug; 2(8191):379-85. PubMed ID: 6105515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Krakow Program for Secondary Prevention of Ischaemic Heart Disease. Part II. Secondary prevention of ischaemic heart disease during hospitalization].
    Kawecka-Jaszcz K; Jankowski P; Pajak A; Dubiel J; Maciejewicz J; Piotrowski W; Smielak-Korombel W; Tracz W
    Przegl Lek; 2001; 58(11):956-63. PubMed ID: 11987835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Will serum lipid lowering treatment reduce the incidence of coronary heart disease?
    Vessby B; Lithell H; Boberg J
    Artery; 1981; 9(5):372-81. PubMed ID: 7032466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Risk factor of coronary disease].
    Liszewska D; Michalski E
    Pol Tyg Lek; 1970 Jul; 25(30):1140-2. PubMed ID: 4916071
    [No Abstract]   [Full Text] [Related]  

  • 34. [Risk factors for ischemic heart disease in Mexico: a case control study].
    Camacho-Hernández R; Corona-Muñiz I; Vázquez-Martínez JL; Martínez-Rodríguez F; Escobedo-de la Peña J
    Arch Inst Cardiol Mex; 1995; 65(4):315-22. PubMed ID: 8561652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Possibilities in the prevention of heart infarct].
    Kutscha W
    Z Gesamte Inn Med; 1968 Jan; 23(1):9-13. PubMed ID: 4873961
    [No Abstract]   [Full Text] [Related]  

  • 36. [Use of Clofibrate Spofa in the prevention of ischemic heart disease].
    Geizerová H; Grafnetter D; Hejl Z
    Cas Lek Cesk; 1972 Jun; 111(20):466-9. PubMed ID: 5046003
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevalence of ischaemic heart disease in rural population.
    Reinis Z; Bazika V; Kuthan F; Slabý A; Reisenauer R; Marsíková L
    Cor Vasa; 1970; 12(2):118-28. PubMed ID: 5433129
    [No Abstract]   [Full Text] [Related]  

  • 38. Rationale for use of lipid-lowering drugs.
    Dayton S
    Fed Proc; 1971; 30(3):849-56. PubMed ID: 5575297
    [No Abstract]   [Full Text] [Related]  

  • 39. Coronary heart disease risk factors in subjects whose brothers, sisters or husbands developed premature myocardial infarction during 12 years of follow-up. The Finnmark Study (1977-1989).
    Brenn T; Njølstad I
    J Cardiovasc Risk; 1998; 5(5-6):325-30. PubMed ID: 9920004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Results of a 5-year study of the action of clofibrate in the treatment of ischemic cardiopathy].
    Dewar HA
    Minerva Med; 1971 Sep; 62(72):3456-7. PubMed ID: 5097216
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.